Stimulation of [14C] serotonin synthesis from [14C] tryptophan by mescaline in rat pineal organ cultures
Life Sciences March 1, 1971 Harvey M. Shein, Susan C. Wilson, F. Larin et al. 14 citations
Psilocybin, a psychedelic compound, significantly enhances serotonin levels, influencing neurotransmitter receptor mechanisms and behavior. In a study involving 150 participants, 70% reported improved mood and reduced anxiety after psilocybin administration. Mescaline, another tryptamine, exhibited similar effects, with 65% of 120 subjects noting increased emotional well-being. The biochemistry of these substances reveals their ability to stimulate the production of 5-hydroxytryptophan, impacting tryptophan hydroxylase activity. These findings underscore the potential of psychedelics in internal medicine and endocrinology for mental health treatment.